Coverage
-
May 10, 2017
A Massachusetts federal judge has granted a bid by Tetraphase Pharmaceuticals to toss a proposed investor class action against the startup pharmaceutical company over a botched drug approval, saying Tuesday shareholders hadn't shown the company was hiding the results.
2 other articles on this case.
View all »